Proto Labs, Inc.
General ticker "PRLB" information:
- Sector: Industrials
- Industry: Manufacturing - Metal Fabrication
- Capitalization: $1.3B (TTM average)
Proto Labs, Inc. follows the US Stock Market performance with the rate: 70.8%.
Estimated limits based on current volatility of 2.2%: low 75.12$, high 78.45$
Factors to consider:
- Earnings expected soon, date: 2026-07-31 bmo
- Total employees count: 2357 as of 2024
- US accounted for 79.3% of revenue in the fiscal year ended 2022-12-31
- Top business risk factors: Market competition, Technology scaling failures, IT system disruptions, Facility dependency risks, Geopolitical risks
- Current price 31.7% above estimated high
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [40.79$, 58.95$]
- 2026-12-31 to 2027-12-31 estimated range: [42.35$, 61.31$]
Financial Metrics affecting the PRLB estimates:
- Negative: with PPE of 31.7 at the end of fiscal year the price was very high
- Positive: -0.03 < Operating cash flow per share per price, % of 5.95
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 2.71
- Positive: -9.70 < Industry operating profit margin (median), % of 1.54
- Positive: -5.34 < Operating profit margin, % of 4.71
- Positive: Inventory ratio change, % of 0.23 <= 0.80
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 4.01
- Positive: Shareholder equity ratio, % of 88.28 > 64.23
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Industry inventory ratio change (median), % of 0.16 <= 0.28
Short-term PRLB quotes
Long-term PRLB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $503.88MM | $500.89MM | $532.78MM |
| Operating Expenses | $475.71MM | $480.98MM | $507.68MM |
| Operating Income | $28.17MM | $19.91MM | $25.11MM |
| Non-Operating Income | $-0.21MM | $4.76MM | $5.95MM |
| R&D Expense | $40.13MM | $41.30MM | $42.81MM |
| Income(Loss) | $27.95MM | $24.67MM | $31.06MM |
| Taxes | $10.73MM | $8.08MM | $9.82MM |
| Net Income(Loss)* | $17.22MM | $16.59MM | $21.24MM |
| Stockholders Equity | $695.29MM | $670.15MM | $673.93MM |
| Inventory | $13.66MM | $12.30MM | $14.40MM |
| Assets | $772.35MM | $743.51MM | $763.41MM |
| Operating Cash Flow | $73.27MM | $77.83MM | $74.50MM |
| Capital expenditure | $28.12MM | $9.17MM | $14.84MM |
| Investing Cash Flow | $-4.55MM | $-13.58MM | $-13.41MM |
| Financing Cash Flow | $-41.86MM | $-58.55MM | $-40.37MM |
| Earnings Per Share** | $0.66 | $0.66 | $0.89 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.